AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25526439
Drug: Hydroxyurea at
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea at 20 mg/kg/day for 2 years, then escalated to 30 mg/kg/day during extension study.
Trial: 25526439
Drug: Hydroxyurea at
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea at 30 mg/kg/day, then decreased to 26 mg/kg/day (range 19.5-31.2).
Trial: 25526439
Drug: Hydroxyurea therapy.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea therapy.
Trial: 20527138
Drug: Onion extract
RxNorm normalized name: Onion Extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onion extract cream with Centella asiatica and hyaluronic acid applied twice daily for 12 weeks
Trial: 20527138
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control) applied to the contralateral side
Trial: 15228673
Drug: rhG‐CSF 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhG‐CSF 75 micro g per day s.c. for 5 ‐ 7 days, additional 3 ‐ 5 days according to leukopenia during radiotherapy
Trial: 9113582
Drug: Topical bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical bupivacaine hydrochloride plus 0.1 mL subconjunctival lignocaine
Trial: 3257288
Drug: Anti-thymocyte globulin
RxNorm normalized name: ANTI-THYMOCYTE GLOBULIN
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-thymocyte globulin (ATG) 15 mg/kg/day
Trial: 3257288
Drug: Anti-thymocyte globulin
RxNorm normalized name: ANTI-THYMOCYTE GLOBULIN
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-thymocyte globulin (ATG) 15 mg/kg/day for 10 days
Trial: 3257288
Drug: Anti-thymocyte globulin
RxNorm normalized name: ANTI-THYMOCYTE GLOBULIN
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-thymocyte globulin (ATG) 15 mg/kg/day for 28 days
Trial: 31777949
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg UPA per day for 5 days
Trial: 28335012
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion for working memory improvement (4 sessions of 1 hour each)
Trial: 28335012
Drug: Active control
RxNorm normalized name: Accu-Chek Active Control Solution
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active control group (no hypnotic suggestion)
Trial: 28335012
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion for working memory improvement
Trial: 21640056
Drug: Active conservative
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active conservative treatment (pelvic floor muscle training - PFMT) delivered by a specialist continence physiotherapist or nurse
Trial: 21640056
Drug: Active conservative
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active conservative treatment (PFMT)
Trial: 19537306
Drug: Margarine fortified
RxNorm normalized name: MARGARINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Margarine fortified with 200 microg folic acid/10 g portion (centre M)
Trial: 16280233
Drug: Written text
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Written text with basic oral explanations (Control)
Trial: 14756716
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (150 mg) + lower intensity counseling
Trial: 14756716
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (150 mg) + higher intensity counseling
Trial: 14756716
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (300 mg) + lower intensity counseling
Trial: 14756716
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (300 mg) + higher intensity counseling
Trial: 11425939
Drug: Deprenyl treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deprenyl treatment
Trial: 3900847
Drug: Tocopherol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocopherol treatment
Trial: 11425939
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of deprenyl and tocopherol
Trial: 9262882
Drug: 0.33 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.33 mg/kg PPA
Trial: 9262882
Drug: 0.66 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.66 mg/kg PPA
Trial: 9262882
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg PSE
Trial: 9262882
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg PSE
Trial: 8334179
Drug: 1.8 g
RxNorm normalized name: Calciquid, 1.8 g/5 mL oral syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g protein/kg/day (high N diet)
Trial: 8334179
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g protein/kg/day (low N diet)
Trial: 23539236
Drug: Dexamethasone (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (14 mg tapered over 3 days)
Trial: 23539236
Drug: Intensive glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive glucose control (80-110 mg dl(‐1))
Trial: 23539236
Drug: Conventional glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional glucose control (180-200 mg dl(‐1))
Trial: 17904917
Drug: Patient preference
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient preference depression treatment
Trial: 12960555
Drug: Inhaled morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled morphine (3 inhalations [6.6 mg])
Trial: 12960555
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (4 mg)
Trial: 12960555
Drug: Inhaled morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled morphine (1 inhalation [2.2 mg])
Trial: 10583449
Drug: Remikiren (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remikiren (600 mg day‐1) single dose
Trial: 10583449
Drug: Remikiren (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remikiren (600 mg day‐1) multiple doses (8 days)
Trial: 2021138
Drug: Increased dietary
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Increased dietary calcium (milk supplement, 831 mg/d)
Trial: 2021138
Drug: Placebo drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo drink (41 mg/d)
Trial: 23016532
Drug: Skincare regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skincare regimen containing retinol, adenosine, and hyaluronic acid applied for 2 months after botulinum toxin A injection
Trial: 19909752
Drug: Peginterferon alfa-2a
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa-2a 180 microg/wk plus ribavirin 1000/1200 mg/day for 48 weeks (group A)
Trial: 19909752
Drug: Peginterferon alfa-2a
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa-2a 180 microg/wk plus ribavirin 1000/1200 mg/day for 72 weeks (group B)
Trial: 12042561
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 20 mg/kg/d
Trial: 12042561
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 30 mg/kg/d
Trial: 12042561
Drug: Amoxicillin 50
RxNorm normalized name: amoxicillin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 50 mg/kg/d
Trial: 1234631
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with melphalan
Trial: 27277839
Drug: B-clade Tat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-clade Tat immunization (30 μg, intradermally, three times at 4-week intervals)
Trial: 22872346
Drug: Educational actions
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational actions on oral health (school and home visits)
Trial: 22872346
Drug: Educational actions
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational actions on oral health (school group)
Trial: 20169425
Drug: Thalidomide, lenalidomide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide, lenalidomide, and bortezomib (new therapies)
Trial: 18946688
Drug: ADCON-L (bioresorbable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADCON-L (bioresorbable carbohydrate polymer gel)
Trial: 18946688
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no ADCON-L)
Trial: 18946688
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (ADCON-L and Control)
Trial: 15567452
Drug: Unfractionated heparin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin, 250 units/kg (n=15)
Trial: 15567452
Drug: Enoxaparin, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, 1 mg/kg (n=16)
Trial: 9524046
Drug: Clonidine (transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (transdermal patch 2.5 mg/week)
Trial: 6351669
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg glucose-free bupivacaine (0.5% or 0.75%)
Trial: 6351669
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg glucose-free bupivacaine (0.5% or 0.75%)
Trial: 6351669
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg glucose-free bupivacaine (0.5% or 0.75%)
Trial: 6351669
Drug: Bupivacaine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (various doses)
Trial: 31815260
Drug: Low-dose L.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose L. casei (1 bottle per day, n = 142)
Trial: 31815260
Drug: High-dose L.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose L. casei (2 bottles per day, n = 143)
Trial: 31815260
Drug: Low-dose L.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose L. casei
Trial: 31815260
Drug: High-dose L.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose L. casei
Trial: 30825384
Drug: Systemic amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic amoxicillin 500 mg/metronidazole 400 mg (3×/day, 7 days, n = 170)
Trial: 29476990
Drug: Oral TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral TXA (3 doses of 2 g oral TXA postoperatively)
Trial: 29476990
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (3 doses of 1 g intravenous TXA postoperatively)
Trial: 27139422
Drug: DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA supplementation (1.16 g DHA/day for 8 weeks)
Trial: 22094353
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (HT, n=34)
Trial: 22094353
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy plus atorvastatin (HT+AT, n=36)
Trial: 21290833
Drug: Medication (Diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Diclofenac Sodium)
Trial: 17704022
Drug: 100 mg/d
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/d gamma-tocopherol
Trial: 17704022
Drug: 200 mg/d
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/d gamma-tocopherol
Trial: 11837380
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ASA (oral)
Trial: 11837380
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg D,L‐lysine‐mono‐acetylsalicylate (Lys‐ASA) (oral and intravenous)
Trial: 11837380
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg Lys‐ASA (oral)
Trial: 9428456
Drug: Total-dose intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total-dose intravenous iron dextran infusion
Trial: 9428456
Drug: 500-mg infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500-mg infusion to total dose
Trial: 9428456
Drug: 100-mg bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-mg bolus to total dose
Trial: 2200632
Drug: Iopromide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide (50 or 100 ml, 370 mgI/ml)
Trial: 2200632
Drug: Iopamidol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol (50 or 100 ml, 370 mgI/ml)
Trial: 7387335
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg beta-endorphin intravenous injection
Trial: 7387335
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg morphine sulfate
Trial: 27810904
Drug: Motolimod (VTX-2337)
RxNorm normalized name: Motolimod
DrugBank: Motolimod (DB12303)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motolimod (VTX-2337) at 3.0 mg/m2 combined with cetuximab
Trial: 27810904
Drug: Motolimod (VTX-2337)
RxNorm normalized name: Motolimod
DrugBank: Motolimod (DB12303)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motolimod (VTX-2337) at 3.5 mg/m2 combined with cetuximab
Trial: 14572304
Drug: Rescue medication
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue medication (oxygen, dexamethasone, acetazolamide)
Trial: 11269488
Drug: Lung volume
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lung volume reduction surgery (LVRS) plus medical therapy
Trial: 2141488
Drug: Diethyl stilboestrol
RxNorm normalized name: Diethyl Phthalate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethyl stilboestrol (DES) 3 mg/day
Trial: 2141488
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg/month
Trial: 271171
Drug: Vigorous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vigorous treatment (CAT)
Trial: 31492102
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment based on Surviving Sepsis Campaign guidelines)
Trial: 21324133
Drug: Directly Administered
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directly Administered Antiretroviral Therapy (DAART) for 12 months
Trial: 17061611
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (2000 mg per day for 20 days)
Trial: 9713447
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 1600 micrograms per day
Trial: 2493897
Drug: Captopril (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (two 25 mg doses in 24 hours)
Trial: 2493897
Drug: Placebo (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (two tablets in 24 hours)
Trial: 31264510
Drug: PF-06412562 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06412562 45 mg
Trial: 31264510
Drug: PF-06412562 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06412562 (3 mg, 9 mg, 45 mg)
Trial: 28364099
Drug: Dexmedetomidine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1.0 μg/kg loading dose for 10 min followed by 0.5 μg/(kg.h) during OLV)
Trial: 25645599
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (15 minutes daily)
Trial: 21336094
Drug: E-MA-H low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E-MA-H low dose (HLD)
Trial: 21336094
Drug: E-MA-H high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E-MA-H high dose (HHD)
Trial: 11421839
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg hyperbaric bupivacaine injected through a 24G Sprotte needle, sitting for 1 min before supine position
Trial: 11421839
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg hyperbaric bupivacaine injected through a 27G Whitacre needle, sitting for 1 min before supine position
Trial: 11421839
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg hyperbaric bupivacaine injected through a 24G Sprotte needle, sitting for 4 min before supine position
Trial: 11421839
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg hyperbaric bupivacaine injected through a 27G Whitacre needle, sitting for 4 min before supine position
Trial: 2939715
Drug: Diclofenac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (50 to 75 mg daily, or up to 150 mg per day for longer-term use)
Trial: 8895942
Drug: Levomethadone maintenance
RxNorm normalized name: levomethadone
DrugBank: Levomethadone (DB13515)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levomethadone maintenance therapy
Trial: 8895942
Drug: Drug-free placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-free placebo control group
Trial: 27251956
Drug: Group L
RxNorm normalized name: Blood group Lewis alpha-4-fucosyltransferase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group L (levobupivacaine and fentanyl)
Trial: 21342456
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplement (50 g, 264 kcal)
Trial: 21342456
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplement (25 g, 130 kcal)
Trial: 21342456
Drug: Corn-soy flour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn-soy flour (71 g, 282 kcal)
Trial: 8695926
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy protocol of six days
Trial: 8695926
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy protocol of one day
Trial: 6196073
Drug: Bendrofluazide (thiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide (thiazide treatment)
Trial: 6196073
Drug: Bendrofluazide (long
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide (long term treatment)
Trial: 6196073
Drug: Bendrofluazide with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide with potassium supplements (long term treatment)
Trial: 6196073
Drug: Placebo (long
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (long term treatment)
Trial: 21403978
Drug: H. persicum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. persicum extract (500 mg/day) + atorvastatin (10 mg/day) for 8 weeks
Trial: 21403978
Drug: Atorvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20 mg/day) for 8 weeks
Trial: 19564812
Drug: Inactivated virosomal‐adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated virosomal‐adjuvanted subunit influenza vaccine (n = 90)
Trial: 19564812
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n = 90)
Trial: 11507355
Drug: amoxycillin 1
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amoxycillin 1 g bid, metronidazole 500 mg bid, bismuth sub‐citrate 240 mg bid and ranitidine 300 mg bid for 1 week
Trial: 11507355
Drug: triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triple therapy without ranitidine for 2 weeks
Trial: 11507355
Drug: triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triple therapy plus ranitidine 300 mg bid for 2 weeks